Skip to content
Chairman & CEO, Xontogeny
Head, Corporate Affairs, Alexion, AstraZeneca Rare Disease
Immediate Past Chair
Immediate Past Chair, MassBio
Managing Partner, RAZR Consulting
President & CEO, Waters Corporation
President & CEO, Anika Therapeutics, Inc.
President & Chief Business Officer, RareStone Inc.
President & CEO, Theseus Pharmaceuticals
President & CEO, Genocea Biosciencs, Inc.
Vice President, Discovery Biotherapeutics, East Coast, Bristol Myers Squibb
Chief Operating & Legal Officer, bluebird bio
Managing Director, Life Sciences, JLL
President & CEO, Organogenesis Inc.
Principal, RMG Associates
Chief Executive Officer, Kojin Therapeutics
Chief Investor Relations & Communications Officer, Section 32 Ventures
Managing Director, AMR Action Fund
Executive VP, CPO, COS, Vertex
SVP, Value and Access, Biogen
Vice President and Head, BD&L Boston & European Innovation Hubs, Merck & Co., Inc.
Head of Global Oncology Patient Value, Policy and Access, Takeda
Managing Director, American Cancer Society’s BrightEdge Fund
Co-founder, President & CEO, Frequency Therapeutics
Vice President/General Manager, Viral Vector Services, Thermo Fisher Scientific
Executive Vice President, R&D, & Chief Medical Officer, Sarepta
Partner, McDermott, Quilty & Miller LLP
Head, Roche Molecular Labs
CEO & Chair, Infinity Pharmaceuticals
Head, Johnson & Johnson Innovation, East North America
Vice President, Government Relations & Public Affairs, Sunovion
Executive Vice President & Head, Sanofi Genzyme
Executive Vice President & CBO, Turning Point Therapeutics
Chief Regulatory Officer, Flexion Therapeutics